在先天性腹膜的"温和"心肺呼吸系统管理:准确医学方法的时间?
相关实验视频
Updated: Jan 15, 2026

06:31
Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
3.5K
Anna Foth1, David Tingay2, Florian Kipfmueller1
1Department of Neonatology and Pediatric Intensive Care Medicine, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
Seminars in fetal & neonatal medicine
|October 9, 2025
概括
生产腹膜 (CDH) 的管理是复杂的. 使用精密医学和温和的心肺支持,根据不同的血液动力学表型量身定制治疗,可以改善婴儿的结果.
科学领域:
- 新生儿重症监护医学 新生儿重症监护医学
- 儿童心脏病学 儿童心脏病学
- 肺高血压研究 肺高血压研究
背景情况:
- 先天性隔膜 (CDH) 带来了新生儿重症监护方面的重大挑战.
- 结局受到肺部低成形,血管重塑和心室功能障碍的影响.
- 目前的治疗方法可能无法解决CDH复杂的生理学问题,导致高死亡率.
研究的目的:
- 在CDH中概述不同的血液动力学表型.
- 提出表型特定的治疗策略.
- 突出精准医学在优化CDH护理中的作用.
主要方法:
- 基于双心脏功能和肺高血压的表型.
- 对血液动力学形状的新兴证据的审查.
- 整合多式监测 (心声,超声,EIT,生物标志物).
主要成果:
- 确定了三个血液动力学表型:功能保留,毛囊前PH和毛囊后PH与LV功能障碍.
- 每种表型都需要不同的呼吸和药理方法.
- 肺部保护策略和温和的心肺支持至关重要.
结论:
- 精准医学方法对于CDH管理至关重要.
- 多式联运监测使得量身定制的干预措施成为可能.
- 优化血液动力学平衡和最大限度地减少阴性损伤可以提高CDH的生存率和长期结果.
相关概念视频
Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Mitral Stenosis III: Medical Management
246
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
246
Acute Respiratory Failure-V
455
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
455
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
586
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
586
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Cardiomyopathy II: Dilated Cardiomyopathy
468
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
468

